Convey Health Solutions Announces Proposed 13.3M Share IPO Between $14-$16/sh

Convey Holding Parent, Inc. (NYSE: CNVY), a leading healthcare technology and services company, today announced it has launched the roadshow for the initial public offering of 13,333,334 shares of its common stock, with 11,666,667 shares to be offered by the Company and 1,666,667 shares to be offered by a selling stockholder pursuant to a registration statement filed on Form S-1 with the Securities and Exchange Commission (the "SEC"). The underwriters will have a 30-day option to purchase up to an additional 2,000,000 shares of common stock from the selling stockholder at the initial public offering price, less underwriting discounts and commissions. The price range for the initial public offering is currently estimated to be between $14.00 and $16.00 per share. The Company has applied to list its common stock on the New York Stock Exchange under the ticker symbol "CNVY."

The Company intends to use the net proceeds that it receives from the proposed offering to repay amounts outstanding under its existing indebtedness and for general corporate purposes. The Company will not receive any proceeds from the sale of shares of common stock by the selling stockholder.

BofA Securities, Goldman Sachs & Co. LLC and J.P. Morgan are acting as lead book-runners and representatives of the underwriters for the offering, with Barclays acting as a joint book-runner. TPG Capital BD, LLC and Truist Securities are also acting as joint book-runners for the offering, and Canaccord Genuity is acting as joint lead manager. AmeriVet Securities and Siebert Williams Shank are acting as co-managers for the offering.

You May Also Be Interested In

• Singularity Future Technology closes $5M registered direct offering
• ESS Tech closes $3.2M stock offering at $0.50 per share
• Nscale targets up to $3B in US IPO as soon as September - Bloomberg